Patient-Reported (EORTC QLQ-CIPN20) Versus Physician-Reported (CTCAE) Quantification of Oxaliplatin- and Paclitaxel/Carboplatin-Induced Peripheral Neuropathy in NCCTG/Alliance Clinical Trials

PURPOSE: Clinical practice guidelines on chemotherapy-induced peripheral neuropathy (CIPN) use the NCI Common Terminology Criteria for Adverse Events (CTCAE), while recent clinical trials employ a potentially superior measure, the European Organization for Research and Treatment of Cancer Quality of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Support Care Cancer
Hlavní autoři: Le-Rademacher, Jennifer, Kanwar, Rahul, Seisler, Drew, Pachman, Deirdre R., Qin, Rui, Abyzov, Alexej, Ruddy, Kathryn J., Banck, Michaela S., Lavoie Smith, Ellen M., Dorsey, Susan G., Aaronson, Neil K., Sloan, Jeff, Loprinzi, Charles L., Beutler, Andreas S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693734/
https://ncbi.nlm.nih.gov/pubmed/28634656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-017-3780-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky